R&D projects
Every year, CIDETEC develops hundreds of applied R&D projects of high strategic value together with national and international customers, both in the private and public sectors.
These projects give rise to new scientific and technological developments, the generation of technology and its transfer to companies, allowing them to improve processes or create new products and services.
CIDETEC also participates in European (Horizon Europe, Horizon 2020), national (PERTE, CIEN, CERVERA…) and regional (HAZITEK, ELKARTEK…) R&D consortium projects.
Force Repair
Smart and Multifunctional 3D Printable Pro-Regenerative Biological Matrix Modulating Mechanotransduction as Advanced Therapy to Treat Skin Chronic Wounds.
Start:2023
End:2027
bmG21
Development of effective tools and protocols for the delivery and release of drugs by different routes of administration.
Start:2021
End:2022
SINPAIN
A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis.
Start:2022
End:2026
cmRNAbone
3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients.
Start:2020
End:2024
TB-MED
An Open Innovation test bed for the development of high-risk medical devices
Start:2019
End:2023
NanoPilot
A Pilot Plant for the production of Polymer based Nanopharmaceuticals in Compliance with GMP
Start:2015
End:2018
PneumoNP
Nanotherapeutics to Treat Antibiotic Resistant Gram-Negative Pneumonia Infections
Start:2014
End:2017
PeptiCaps
PeptiCaps aims at producing and validating a new family of stimuli-responsive nanocapsules as coosmtetic product by the authorities.
Start:2015
End:2018
